Neuralink says 12 people have received its brain implants as company expands human trials
Neuralink said 12 people have received its N1 brain implant, a wireless brain-computer interface that enables people with paralysis to control computers and robotic devices by thought, as the company moves to expand human trials to dozens of procedures.
Key takeaways
- 12 people have received its N1 brain implant, according to company reporting; Neuralink was founded by Elon Musk in 2016.
- The device is a brain-computer interface made of a small chip and hair-thin threads placed in the brain region tied to movement intent, with additional reporting on placement and recipients here.
- Recipients with severe paralysis use the implant to control computers, send emails, and run design tools, per reporting linked to coverage.
- Neuralink plans to scale trials to as many as 20–30 implants this year, aiming to further test safety and performance.
Main content
What Neuralink says
Neuralink states its N1 implant can translate neural signals tied to movement into digital commands. The chip connects to hair-thin threads that sit in a brain area linked to intent to move, and signals are sent wirelessly to external devices.
The company provided public updates and filings as it expanded the trial, reporting 12 human recipients and describing iterative changes to the implant. Company disclosures and reporting note adjustments in placement depth and surgical technique to limit thread retraction and device issues (Observer).
“The N1 system translates neural activity tied to intent into commands,” Neuralink says as it refines hardware and software for stability and performance.
Who the patients are and what they can do
One of the first publicly known recipients, Noland Arbaugh, a quadriplegic, demonstrated the ability to play chess, browse the web, send emails, and control computers using the implant and software (coverage at Observer and EM360Tech).
At institutions like Barrow Neurological Institute, some trial participants have used the implant for professional tasks, including computer-aided design (CAD). Reports show high accuracy for basic cursor control in some users—Neuralink cites up to ~90% accuracy for moving a computer cursor—though fine motor tasks remain under study (CGTN).
Technical and clinical details
The N1 system consists of a small implantable chip and flexible threads that record brain activity. A robotic surgical system places the threads into targeted brain tissue, and the device wirelessly transmits data to external receivers running decoding software.
Neuralink has iterated its design, making deeper placements and refining surgical steps after early recipients experienced some loosening or retraction of threads. Many issues were reportedly addressed with software updates and hardware tweaks (Observer; EM360Tech).
Clinical work remains early. Trials such as the PRIME study are monitoring how well the implant supports everyday tasks and long-term use (CGTN).
Plans to scale up
Neuralink has expressed plans to increase human implants this year, targeting up to 20–30 procedures to test safety, durability, and performance across more people and conditions (Observer).
Ethical, safety and regulatory questions
Controversies and risks: Neuralink’s program has drawn scrutiny over past animal testing and treatment of research subjects (EM360Tech).
- Surgical implants pose risks such as infection, bleeding, and long-term tissue response.
- There are data privacy and security concerns: brain data could reveal sensitive information if not properly protected.
- Regulatory scrutiny is substantial; broad approvals require convincing safety and benefit data and transparent reporting (Observer).
What experts want to see
Neurologists and bioethicists request detailed clinical data made public, randomized trials, long-term follow-up, and open reporting of adverse events. They also call for strong safeguards for patient consent and protection of neural data as implants increase.
Reporting notes and sources
This article draws on public reporting and company disclosures, including coverage of patient demonstrations and clinical study participation. Primary sources include TechSpot, Observer, CGTN, and EM360Tech.
Implications for the Inland Empire
Economic impact
Neuralink’s progress could create demand for local medical and tech services in the Inland Empire (Riverside and San Bernardino counties). Opportunities may arise for clinics, surgical centers, rehabilitation providers, medical device vendors, and wireless hardware suppliers.
Health care system and jobs
If trials expand locally, hospitals and neurosurgeons may be involved in care, training, and follow-up, creating specialized jobs and training for nurses, therapists, and device technicians. Local patients could gain access without traveling to distant centers.
Political consequences
Elected leaders and health officials will face questions on zoning, funding for disability services, and oversight of trials that recruit locally. Neuralink’s growth may enter debates on economic development and medical regulation.
Social effects and cultural relevance
For residents with neurological conditions, implants could offer new independence and reduced travel for specialty care. Yet high cost and experimental status may limit access. Local values around family care mean stories of regained function will resonate, while past concerns about testing may increase skepticism.
Practical applications for residents
- Patients: Potential for improved communication, work, and device use for people with paralysis or ALS in the region.
- Providers: Need for training and new rehabilitation programs centered on BCIs.
- Employers: Opportunities to hire workers using assistive technologies if accommodations are available.
- Policymakers: Updates to consent rules, data protections, and clinical oversight will be needed to handle neural data and new procedures safely.
Questions for local stakeholders
Local hospitals, disability groups, and county health officials should ask:
- Will local medical centers be part of trials or offer follow-up care?
- How will patient data be stored and protected?
- What training will local clinicians receive?
- How will access be made fair and affordable?
As Neuralink moves forward, Inland Empire leaders and health providers will shape how brain-computer interface technology reaches residents. Detailed planning and public engagement could help capture benefits while managing risks.
